Delivery & Manufacture at the World Orphan Drug Congress

 

Strategy, advocacy and partnering for the orphan drug industry

2-5 November 2020

Melia Sitges Hotel Resort, Barcelona, Spain

 

 
700+
Attendees
350+
Companies
200+
Speakers
80%
Decision Makers
2
Co-located events

Delivery & Manufacture

 

➤  Improving cell & gene therapy supply and manufacturing

➤  Scaling gene therapy: What is the goal?

➤  Advancement of analytical tools for testing and characterization of AAV gene therapy products

➤  Strategies and advances in lentiviral vector manufacturing and scale-up

➤  How can advanced therapy companies make their manufacturing process more cost effective and sustainable?

2019 KEY SPEAKERS

 

Philip Wills , Chief Commercial Officer , Catalent Paragon Gene Therapy

Philip Wills | Chief Commercial Officer | Catalent Paragon Gene Therapy » speaking at Orphan Drug Congress

Dr Frederic Revah , Chief Executive Officer , Genethon

Dr Frederic Revah | Chief Executive Officer | Genethon » speaking at Orphan Drug Congress

Jean-Philippe Combal , Co-Founder And Chief Executive Officer , Vivet Therapeutics

Jean-Philippe Combal | Co-Founder And Chief Executive Officer | Vivet Therapeutics » speaking at Orphan Drug Congress

Peter Olagunju , Vice President Of Global Patient Operations , bluebird bio

Peter Olagunju | Vice President Of Global Patient Operations | bluebird bio » speaking at Orphan Drug Congress

Mark Galbraith , Head Of Quality Control And Analytical Sciences , Spark Therapeutics

Mark Galbraith | Head Of Quality Control And Analytical Sciences | Spark Therapeutics » speaking at Orphan Drug Congress